Perspective Therapeutics, Inc. (CATX)
4.71
-0.31
(-6.18%)
USD |
NYAM |
Feb 13, 16:00
4.82
+0.11
(+2.34%)
After-Hours: 17:30
Perspective Therapeutics Free Cash Flow : -106.85M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.917B |
| Accuray, Inc. | 11.11M |
| Alphatec Holdings, Inc. | -3.35M |
| Boston Scientific Corp. | 3.824B |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.29M |
| Cash from Investing (Quarterly) | 13.99M |
| Cash from Financing (Quarterly) | 0.213M |
| Free Cash Flow Per Share (Quarterly) | -0.2466 |
| Free Cash Flow to Equity (Quarterly) | -18.07M |
| Free Cash Flow to Firm (Quarterly) | -18.26M |
| Free Cash Flow Yield | -31.12% |